Sinclair BioResources
Sinclair BioResources is a private US firm that breeds and sells four lines of purpose-bred miniature swine (Sinclair Nanopig®, Hanford™, Yucatan™, Micro-Yucatan™) and validated disease models to biopharma, academic, and medical-device researchers for preclinical drug safety, efficacy, and surgical studies.
- Company typePrivate
- Founded1994
- HeadquartersAuxvasse, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sinclair BioResources does
Sinclair BioResources (operating as Sinclair Bio Resources, legal entity Sinclair BioResources LLC, founded 1994, headquartered in Auxvasse, Missouri) is a privately held producer of purpose-bred miniature swine and validated disease models for the biomedical research industry. The company maintains four registered breed lines — Sinclair Nanopig®, Hanford™, Yucatan™, and Micro-Yucatan™ — across a 650-acre, 300,000+ sq ft AAALAC-accredited Missouri campus and a 27-acre Maine production facility. Its scientific portfolio includes eight characterized disease models spanning cardiovascular (atherosclerosis, spontaneous VSD), metabolic (Type 1/Type 2 diabetes, obesity), orthopedic (osteopenia/osteoporosis), oncologic (spontaneous regressing malignant melanoma), transplantation (MHC-defined Yucatan lineages with cloned/sequenced SLA genes), and surgical/blast-trauma applications, all supported by a proprietary Behavior Enhancement System™ (BES™) that conditions animals via positive reinforcement from birth. The company's competitive positioning rests on its role as the only private firm primarily engaged in large animal model development, multi-decade pedigree records, USDA/AAALAC/GLP regulatory standing, and the annually updated Book of Normals reference dataset.
Revenue is generated through direct, quote-based enterprise sales to three primary segments: the biopharmaceutical industry (preclinical drug safety and efficacy testing), university and academic research institutions (basic and disease-modeling research), and medical device companies (cardiovascular device, surgical, and trauma studies). The go-to-market relies on a small specialized field-sales motion supported by conference presence (SOT, AALAS, ACT), a resource-driven website (white papers, publications, Book of Normals), LinkedIn/YouTube content, and inbound quote requests; delivery is fulfilled via AAALAC-accredited climate-controlled transport or approved airfreight. The product mix combines one-time animal and bioproduct sales (whole blood, plasma, serum, tissues), pre-shipping alteration services performed in GLP spirit (castration, ovariectomy, vascular access port placement, diabetes induction, biopsies), and reference-data/content offerings, with multi-year contract cadences typical for institutional accounts.
Sinclair BioResources firmographics
Firmographics- Name
- Sinclair BioResources
- Legal name
- Sinclair BioResources LLC
- Website
- https://sinclairbioresources.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sinclair BioResources is a private US firm that breeds and sells four lines of purpose-bred miniature swine (Sinclair Nanopig®, Hanford™, Yucatan™, Micro-Yucatan™) and validated disease models to biopharma, academic, and medical-device researchers for preclinical drug safety, efficacy, and surgical studies.
- Ownership category
- akta.pro rank
Sinclair BioResources industry classification
Industry- Product category
- Preclinical Research Animal Models
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Companion/Specialty Animal Breeding & Genetics Services (non-livestock) (AFAEAJAO)
Keywords
Where Sinclair BioResources is headquartered
LocationHeadquarters
- HQ city
- Auxvasse
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Sinclair BioResources business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Miniature Swine Sales: Sale of purpose-bred, socialized miniature swine (Sinclair Nanopig®, Hanford™, Yucatan™, Micro-Yucatan™) to biomedical research clients. Animals are delivered via climate-controlled transport or airfreight.
- Animal Models: Specialized disease models including osteopenia, diabetes, atherosclerosis, melanoma, VSD, obesity, and surgical models developed for preclinical research applications.
- Bioproducts: Biosamples including whole blood, plasma, serum, and tissues from miniature swine and other domestic species collected daily.
- Support Services: Pre-shipping alterations performed in GLP spirit including castration, ovariectomy, vascular access port placement, diet feeding, diabetes induction, test article administration, and biopsies. Also includes Book of Normals reference data.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quotation based on animal model and services required |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Sinclair BioResources product offering
Product offeringCore offering
Sinclair BioResources breeds, raises, and sells purpose-bred miniature swine (Sinclair Nanopig, Hanford, Yucatan, and Micro-Yucatan lineages) and supplies specialized disease models, biosamples (whole blood, plasma, serum, tissues), and pre-shipping alteration services to biopharmaceutical companies, medical device firms, and academic research institutions for preclinical drug development and biomedical research.
Product overview
Sinclair BioResources is a biomedical research company specializing in the production of miniature swine for drug development and preclinical research. The company offers four distinct breeds of miniature swine (Sinclair Nanopig®, Hanford, Yucatan™, and Micro-Yucatan™) along with a proprietary Behavioral Enhancement System™ for animal conditioning. The portfolio includes eight characterized animal models for specific disease research (osteopenia/osteoporosis, diabetes, atherosclerosis, melanoma, VSD, transplantation, obesity, and surgical modeling), bioproducts (biosamples), and the Miniature Swine Book of Normals resource. Sinclair is the only private company primarily involved in large animal model development for the biomedical industry.
Differentiator
Problem solved
Functional benefit
Brands
- Sinclair Nanopig®: First miniature swine stock developed specifically for research purposes, characterized through whole genome sequencing and tissue-based proteomics for drug safety assessment.
- Hanford™ Miniature Swine
- Yucatan™ Miniature Swine
- Micro-Yucatan™ Miniature Swine
- Behavior Enhancement System™
Products and services
- Sinclair Nanopig The first miniature swine stock developed specifically for biomedical research, characterized through whole genome sequencing and tissue-based proteomics for drug safety assessment. One lineage develops a malignant spontaneously regressing melanoma and is used across cardiovascular, musculoskeletal, oncology, immunology, and dermatology research.
- Hanford Miniature Swine Well-adapted laboratory miniature swine with white skin and haircoat, used predominantly as a dermal toxicology model. Heart size and collateral blood flow are very similar to human hearts, making it an excellent cardiovascular model.
- Yucatan Miniature Swine Closed and fully-pedigreed miniature swine colony available with white hairless lineage for dermal studies and Ventricular Septal Defect lineage. The Missouri colony is MHC haplotype-defined for transplantation studies with SLA class I and II genes cloned, sequenced, and characterized.
- Micro-Yucatan Miniature Swine Particularly known for docile temperament and ease of handling, with darkly pigmented skin and little or no hair. Available with a spontaneous Ventricular Septal Defect (VSD) model and used as a large animal cardiovascular model.
- Osteopenia and Osteoporosis Animal Model Osteopenia and osteoporosis model using miniature swine with lamellar bone and trabecular/cortical remodeling similar to humans. Includes a young adult model with calcium-restricted diet and ovariectomies, and adult models with gradual bone loss (11.6% spine and 21.1% femur density loss within 10 months after gastrocnemectomy).
- Type 1 and Type 2 Diabetes Animal Model Type 1 DM induced using streptozotocin or alloxan, and Type 2 DM with dyslipidemia induced in miniature swine. Lipid profiles are similar to diabetic humans with early atherosclerosis lesions. Also used for whole pancreas or islet cell transplantation research for potential cure of Type 1 DM.
- Atherosclerosis Animal Model Atherosclerotic miniature swine model accelerated by intimal injury via balloon rasping, high fat/high cholesterol diets, blood flow restriction, or diabetes induction. Pigs naturally develop atherosclerosis similar to humans.
- Spontaneous Regressing Malignant Melanoma Animal Model Sinclair miniature swine develop aggressive melanoma similar to humans with unique spontaneous regression after metastatic phase. Provides opportunity to study host-tumor-cell interactions and therapeutic compounds.
- Spontaneous Ventricular Septal Defect (VSD) Animal Model Heritable VSD model produced in Yucatan and Micro-Yucatan miniature swine through selective breeding. Defect diagnosable in utero or postnatally with similarities to human VSD for preclinical treatment applications.
- MHC Defined Lineages for Transplantation Model Yucatan miniature swine colony with MHC haplotype-defined for transplantation studies. SLA class I and II genes cloned and sequenced with allele-specific monoclonal antibody characterizations for xenotransplantation research.
- Obesity and Weight Management Animal Model Obesity model using miniature swine that lay down adipose in the omentum, around kidneys, and subcutaneously. Induced obesity accelerated with high fat, high cholesterol diets.
- Surgical Modeling Large animal models for surgical research including cardiovascular device studies, shock and trauma models, and blast trauma models for medical device companies and academic surgical research.
- Bioproducts (Biosamples) Provides biosamples including whole blood, plasma, serum, and tissues from multiple domestic species and miniature swine, collected daily for biomedical research applications.
- Behavior Enhancement System (BES)
- Pre-shipping Alteration and GLP Support Services Pre-shipping alterations performed in GLP spirit including castration, ovariectomy, vascular access port placement, diet feeding, diabetes induction, test article administration, and biopsies, providing preparation and acclimation services for research clients.
Quantifiable outcome
- Sinclair miniature swine melanoma model shows spontaneous regression after metastatic phase, providing unique opportunity to study tumor-immune interactions
- +2 more outcomes
Companies that use Sinclair BioResources
Customer profileSegments3 records
Ideal customer profiles3 records
Sinclair BioResources technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sinclair BioResources partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Sinclair BioResources competitors and assessment
Company assessmentDirect peers
- Ellegaard Göttingen Minipigs: Danish-based supplier of Göttingen minipigs to the global biomedical research market; the most direct global competitor to Sinclair in purpose-bred miniature swine for preclinical research, with analogous disease-model offerings (diabetes, cardiovascular, dermatology).
- Inotiv: Research-models and preclinical CRO (post-Envigo/Harlan integration) supplying laboratory animals and contract research services to biomedical researchers; competes with Sinclair for biomedical research animal-model budgets, though with a broader model focus beyond swine.
- Marshall BioResources: Specialty breeder of Göttingen minipigs and other research animal models (now part of Charles River); directly competes with Sinclair on purpose-bred swine for biomedical research and historically overlapped on Yucatan lines before Sinclair acquired colonies from them in 2002.
- B&K Universal: Supplier of laboratory animals (miniature swine among other species) for biomedical and pharmaceutical research, comparable to Sinclair in offering purpose-bred swine and ancillary services for preclinical studies.
- Hilltop Lab Animals: AAALAC-accredited U.S. supplier of purpose-bred research animals, including models for cardiovascular and metabolic research; comparable to Sinclair in small, accredited specialty breeder positioning for biomedical research markets.
Broad incumbents
- Charles River Laboratories: Large CRO with a Discovery & Safety Assessment segment historically involved in minipig supply through its acquisition of Marshall BioResources; overlaps with Sinclair in regulated large-animal preclinical models and ancillary services, but operates at much greater scale.
- Jackson Laboratory: Premier nonprofit provider of genetically defined mouse models; comparable to Sinclair as a vertically integrated, genetically characterized animal-model supplier to biomedical research, though focused on rodents rather than swine.
- Taconic Biosciences: Provider of genetically engineered rodent models and research services; relevant peer given its analogous 'defined-genetics + research-services + regulatory quality' model applied to rodents, the same architecture Sinclair uses for swine.
- Crown Bioscience: Global preclinical CRO providing oncology and metabolic disease models including large animal and translational services; partially overlaps with Sinclair on disease-model development and contract preclinical services for biopharma clients.
Regional players
- Janvier Labs: European-based breeder and supplier of laboratory animals (mostly rodent models) for biomedical research; comparable business model to Sinclair's purpose-bred-characterized-research-animal offering, but geographically focused on Europe.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Sinclair BioResources social profiles
Digital presenceSinclair BioResources financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sinclair BioResources leadership team
Management profileNumber of profiles
Profiles2 records
Sinclair BioResources funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sinclair BioResources M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sinclair BioResources
What does Sinclair BioResources do?
Sinclair BioResources breeds, raises, and sells purpose-bred miniature swine (Sinclair Nanopig, Hanford, Yucatan, and Micro-Yucatan lineages) and supplies specialized disease models, biosamples (whole blood, plasma, serum, tissues), and pre-shipping alteration services to biopharmaceutical companies, medical device firms, and academic research institutions for preclinical drug development and biomedical research.
Is Sinclair BioResources a public or private company?
Sinclair BioResources is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Sinclair BioResources founded?
Sinclair BioResources was founded in 1994. It employs 11 to 50 people.
Where is Sinclair BioResources based?
Sinclair BioResources is headquartered in Auxvasse, United States, in the North America region.
How does Sinclair BioResources make money?
Four revenue lines are on record. Miniature Swine Sales are the primary driver. The others are animal Models, bioproducts and support Services.
Who are Sinclair BioResources's main competitors?
Direct peers on record are Ellegaard Göttingen Minipigs, Inotiv, Marshall BioResources, B&K Universal and Hilltop Lab Animals. Broad incumbents are Charles River Laboratories, Jackson Laboratory, Taconic Biosciences and Crown Bioscience. Janvier Labs is listed as a regional player.
Does Sinclair BioResources have an API?
No public API is recorded for Sinclair BioResources.
What industry is Sinclair BioResources in?
Sinclair BioResources's product category is Preclinical Research Animal Models. Its primary akta.pro industry code is AFAEAJAO, Companion/Specialty Animal Breeding & Genetics Services (non-livestock). Its NAICS code is 541714 and its SIC code is 2836.